Delivery Order SPE2DB20D1110-SPE2DB24FK18P
Award Date
5/6/24
Potential Completion Date
5/7/24
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $15,701.69 for the supply of Dupixent 300 mg/2 ml pens. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 19, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $3,304.72 for the supply of the specialty medication Dupixent 300 mg/2 ml pen. The contract is issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $9,655.91 firm fixed-price delivery order is for the supply of the medication Dupixent (300 mg/2 ml pen, 2 ml) to DLA facilities. This award is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen 2ml to the U.S. Department of Defense (DoD) and its Medical Supply Chain agency. The $29,013.39 Firm Fixed Price delivery order contract has an ultimate completion date of April 18, 2024. This award is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $8,991.84 firm fixed price delivery order is for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen (2 ml). The contract has an ultimate completion date of April 24, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $16,769.61 Delivery Order is for the supply of 4,564,361,756 units of the medication Dupixent 300 mg/2 ml pen, with a period of performance through April 23, 2024. Amerisourcebergen holds a larger, single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Dupixent 300 mg/2 ml pen in a 2 ml volume. The contract, valued at $4,725.90, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a unit of the Department of Defense (DoD), and does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $13,720.20 firm fixed-price delivery order contract is for the supply of Dupixent 300 mg/2 ml pens. The contract has an ultimate completion date of May 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of pharmaceutical products and medical supplies, including the drug Dupixent, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $3,766.51, is a Firm Fixed Price Delivery Order with a period of performance through June 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Dupixent 300 mg/2 ml pens. The firm-fixed-price delivery order, valued at $285,598.84, has a completion date of December 31, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...